- Abstracts and a completed abstract form MUST be submitted by 17:00 on Friday 6th October 2017.
- Fax transmissions and postal submissions will not be accepted.
- Abstracts must be submitted as an email attachment in a Windows version of Word and formatted as outlined below.
- Each individual can present one paper only. However you may be listed as co-author on any number of abstracts.
- Please note that two copies of your abstract are required – one full version and one to be anonymised (names, place of work and any identifying information must be removed from the abstract).
- Please download and fill in the abstract submission form. This must be included in your application.
- Your abstract file names should follow the following format:
- Full abstract version – Surname Initial.doc e.g. Smith J.doc
- Anonymised – ANON Surname Initial.doc e.g. ANON Smith J.doc
- All applicants will be informed of the adjudicating committee’s decision by w/c Friday 10th November.
- Any amendments to your abstract must be completed and returned by Monday 27th November.
- Submitted abstracts should relate to original, previously unpublished work contributing to the understanding, development or evaluation of health service or pharmacy practice research
- Abstracts are welcome from qualitative and quantitative research projects.
- We welcome works in-progress provided there is a sufficient amount of results suitable for publishing.
- Papers on any aspect of pharmacy practice or health services research relevant to medicines or pharmacy are invited. We are keen to include a broad range of subject areas and would particularly welcome papers addressing the following subjects:
- Cost effectiveness
- Medicines usage
- Health policy
- Multi-disciplinary teams
- Health promotion
- Prescribing issues
- Interface issues
- Patient perspectives
- Measures of outcomes
- Quality issues
- Non-medical prescribing
- Drug utilisation studies
- Health services policy research
- Pharmacy practice research
- Your abstract should be of the following structure:
- A title (lower case e.g. A cluster randomised controlled…)
- Background – A brief introduction including a statement of aims & objectives or research question
- Methods – A description of the methods used and a statement about ethical approval
- Results – The results obtained
- Discussion/conclusions The conclusions
- Please list all authors’ names under the title. Type all names in lower case, initials followed by family name. Example: J. McElnay, C Hughes, G Crealey.
- Please note subheadings will be removed at publication stage. Please ensure your abstract makes sense without them.
- Where there is more than one author, the presenting author should be named as first author. The names of all authors will appear with the abstract.
- Provide name of institution and email address of corresponding author in lower case. Do not include the full work address.
- Please note that abstracts that do not conform to this structure will not be accepted.
- Abstracts must be typed in Times new Roman font 11 in a single column.
- Tables and references should be typed in Times new Roman font 9.
- The word count for the abstract should be between 350 words and 500 words (or maximum of 350 words if a table or a figure is included).
- The word count does not include the title, authors’ details or references.
- Figures should be black and white and capable of being reproduced clearly when reduced to 55mm wide.
- Figures should be supplied with a high resolution image file in a popular format, such as TIFF or JPEG.
- An example of the correct abstract formatting can be accessed here.
- Abstracts which do not follow these formatting guidelines will not be considered.
- Each abstract should have only two references.
- Abstracts should be in the style of the International Journal of Pharmacy Practice, as follows:
- Do not underline or use italics, except as required by usual convention.
- Do not use lines on tables except on the top and bottom.
- References should be cited in the text as superscript numbers in the Vancouver style e.g. 
- Presentations will be oral communications or posters.
- Oral communications will be a 15 minute presentation followed by a 10 minute discussion.
- There will be a poster discussion forum, where poster presenters will stand by the posters. Posters will be displayed throughout the 2 days of the conference.
- Please indicate on the Abstract Submission Form if you would accept oral or poster or either type of presentation.
Abstract Review Process
- Abstracts will be sent to Adjudicating Committee members who will meet in November 2017 to consider the abstracts. They will use the judging criteria set out on the website.
- Accepted abstracts will be assigned to an appropriate session within the conference on the basis of subject matter and number of abstracts received.
- Receipt of abstracts will be confirmed by email and authors will receive notification of the committee’s decision by w/c 27th November 2017.